Gerald Friedland MD
Professor of Medicine (Infectious Diseases) and of Epidemiology (Microbial Diseases)
Departments & Organizations

Yale Medical Group
Office of International Medical Student Education
Global Health Initiative: HIV/AIDS | Tuberculosis
School of Public Health: Center for Interdisciplinary Research on AIDS
Internal Medicine: Infectious Diseases: AIDS Care Program
Research Interests
HIV care; Injection drug use and HIV; Anti-retroviral agents; Tuberculosis, HIV and TB drug resistant TB; Prevention and treatment in vulnerable populations more...
Education
- M.D., New York University, 1964
Selected Publications
- Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, Weissman D, Marra C, Lalloo UG, Friedland GH: HIV Co-infection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality. American Journal of Respiratory and Critical Care Medicine. 2010; 181:80-86.
- McCance-Katz EF, Moody DE, Prathikanti S, Friedland G, Rainey PM, Rifampin, but not Rifabutin, May Produce Opiate Withdrawal in Buprenorphine-Maintained Patients, Drug and Alcohol Dependence, 2011 Nov 1; 118(2-3):326-34. Epub 2011, May 19
- Shenoi SV, Brooks RP, Barbour R, Altice FL, Zelterman D, Moll AP, Master I, van der Merwe TL, Friedland GH. (2012) Survival from XDR-TB Is Associated with Modifiable Clinical Characteristics in Rural South Africa. PLoS ONE: Research Article, published 06 Mar 2012 10.1371/journal.pone.0031786 PMC3295798.



